SAS code for 3-period, partial-replicated crossover study [RSABE / ABEL]

posted by scorp2011 – India, 2015-06-15 14:36 (3678 d 05:08 ago) – Posting: # 14957
Views: 8,496

We have two Test formulations (T1 and T2) and One single Reference formulation (R). We want to test for bioequivalence of each test formulation against the reference formulation i.e. T1 vs. R and T2 vs. R. The test drug is a candidate of "NTI" Please suggest me the whether we can analyze the study as per the SAS code (after adequately modifying the same) provided by the USFDA in Warfarin OGD guidance.
Regards
Sonu

Complete thread:

UA Flag
Activity
 Admin contact
23,430 posts in 4,931 threads, 1,679 registered users;
33 visitors (2 registered, 31 guests [including 7 identified bots]).
Forum time: 19:44 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5